Cytokinetics (CYTK) Superinvestor holders
20 of the superinvestors we track hold Cytokinetics (CYTK) in their latest 13F filings, $535M in total.
Summary
The largest holder is Steve Cohen (Point72 Asset Management), with $135M, 0.2% of the portfolio.
In their latest quarter: 5 opened a new position, 9 added, 4 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Steve Cohen Point72 Asset Management |
Added | 1,587,712 | $135M | 0.2% | Q2 2026 |
| Brandon Haley Holocene Advisors |
New position | 1,144,579 | $98M | 0.2% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 1,048,103 | $89M | 0.1% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 818,832 | $54M | 0.0% | Q3 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 451,467 | $38M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 317,411 | $27M | 0.0% | Q2 2026 |
| Bernard Horn Polaris Capital Management |
Added | 346,100 | $23M | 2.4% | Q3 2026 |
| Alex Denner Sarissa Capital Management |
Held | 228,623 | $19M | 10.9% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 161,903 | $14M | 0.0% | Q2 2026 |
| Mark Kingdon Kingdon Capital Management |
New position | 157,100 | $13M | 1.8% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
New position | 92,680 | $8M | 0.0% | Q2 2026 |
| Chuck Royce Royce Investment Partners |
Added | 102,285 | $7M | 0.1% | Q3 2026 |
| Thornburg Thornburg Investment Management |
Trimmed | 31,133 | $3M | 0.0% | Q2 2026 |
| Louis Bacon Moore Capital Management |
Held | 25,000 | $2M | 0.1% | Q2 2026 |
| Man Group Man Group plc |
Added | 17,393 | $1M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Trimmed | 11,891 | $1M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Trimmed | 10,000 | $851,900 | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 7,446 | $634,325 | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
New position | 5,367 | $457,215 | 0.0% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
New position | 2,829 | $241,002 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 21 |
| Q1 2026 | 15 |
| Q4 2025 | 16 |
| Q3 2025 | 16 |
| Q2 2025 | 10 |
| Q1 2025 | 15 |
| Q4 2024 | 14 |
| Q3 2024 | 20 |
Questions about Cytokinetics
Which superinvestors own Cytokinetics?
20 of the superinvestors we track hold Cytokinetics (CYTK) in their latest 13F filings, $535M in total. Steve Cohen, Brandon Haley, David Shaw, Ken Fisher, Paul Marshall, Two Sigma.
Who is the largest superinvestor holder of CYTK?
The largest holder is Steve Cohen (Point72 Asset Management), with $135M, 0.2% of the portfolio.
From Cytokinetics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.